Viemed Healthcare (VMD) Cash from Investing Activities (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.94% |
| Dec 31, 2025 | 76.43% |
| Sep 30, 2025 | -1,770.12% |
| Jun 30, 2025 | 79.75% |
| Mar 31, 2025 | 7.26% |
| Dec 31, 2024 | -85.11% |
| Sep 30, 2024 | 55.50% |
| Jun 30, 2024 | -108.15% |
| Mar 31, 2024 | 28.40% |
| Dec 31, 2023 | 11.93% |
| Sep 30, 2023 | 73.58% |
| Jun 30, 2023 | -724.76% |
| Mar 31, 2023 | 47.07% |
| Dec 31, 2022 | -20.89% |
| Sep 30, 2022 | 8.75% |
| Jun 30, 2022 | -75.68% |
| Mar 31, 2022 | 41.99% |
| Dec 31, 2021 | 22.10% |
| Sep 30, 2021 | -175.33% |
| Jun 30, 2021 | -80.21% |
| Mar 31, 2021 | 68.37% |
| Dec 31, 2020 | -121.18% |
| Sep 30, 2020 | -322.46% |
| Jun 30, 2020 | 163.76% |
| Mar 31, 2020 | 33.66% |
| Dec 31, 2019 | 6.05% |
| Sep 30, 2019 | 62.88% |
| Jun 30, 2019 | -7,938.04% |
| Mar 31, 2019 | 95.84% |
| Dec 31, 2018 | -68.98% |